Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational <i>psoriasis study of health outcomes</i> ( <scp>PSoHO</scp> )-Reference-Cited by-同舟云学术

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes ( PSoHO )

Published:2022-07-29 Issue:11 Volume:36 Page:2087-2100
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Pinter Andreas¹^ORCID,Puig Luis²^ORCID,Schäkel Knut³,Reich Adam⁴^ORCID,Zaheri Shirin⁵,Costanzo Antonio⁶⁷^ORCID,Tsai Tsen Fang⁸^ORCID,Smith Saxon D.⁹,Lynde Charles¹⁰,Brnabic Alan¹¹,Reed Catherine¹¹,Hill Julie¹¹,Schuster Christopher¹¹¹²,Riedl Elisabeth¹¹¹²,Paul Carle¹³

Affiliation:

1. Department of Dermatology, Venereology and Allergology University Hospital Frankfurt Frankfurt am Main Germany

2. Department of Dermatology, Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona Barcelona Spain

3. Department of Dermatology University Hospital Heidelberg Germany

4. Department of Dermatology, Institute of Medical Sciences Medical College of Rzeszow University Rzeszow Poland

5. Department of Dermatology Imperial College Healthcare NHS Trust London UK

6. Division of Dermatology Humanitas Research Hospital Pieve Emanuele, Milan Italy

7. Dermatology IRCCS Humanitas Research Hospital Rozzano, Milan Italy

8. Department of Dermatology National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

9. ANU Medical School, ANU College of Health and Medicine The Australian National University Canberra Australia

10. Department of Medicine University of Toronto Toronto Ontario Canada

11. Eli Lilly and Company Indianapolis Indiana USA

12. Department of Dermatology Medical University of Vienna Vienna Austria

13. Paul Sabatier University and Larrey Hospital Toulouse France

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18376

Reference32 articles.

1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

2. Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials

3. Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ

4. Psoriasis Therapy in Real Life: The Need for Registries

5. Psoriasis registries worldwide: systematic overview on registry publications

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO);Dermatology and Therapy;2023-12-19

2. Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-12

3. Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-10-31

4. Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO);Clinical, Cosmetic and Investigational Dermatology;2023-10

5. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10